Joint AIDS Foundation Slow to Form

WASHINGTON—More than four months after researchers in the United States and France agreed to share credit for the discovery of the AIDS virus, the international foundation, they proposed to help fight the disease has yet to emerge from the necessary paperwork. The Department of Health and Human Services recently received the signatures of 15 scientists from HHS and the Pasteur Institute that are needed to set up the foundation, said Robert Charrow, HHS deputy general counsel. A request

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WASHINGTON—More than four months after researchers in the United States and France agreed to share credit for the discovery of the AIDS virus, the international foundation, they proposed to help fight the disease has yet to emerge from the necessary paperwork.

The Department of Health and Human Services recently received the signatures of 15 scientists from HHS and the Pasteur Institute that are needed to set up the foundation, said Robert Charrow, HHS deputy general counsel. A request must be filed with the U.S. Patent and Trademark Office to amend the patent applications of both countries to reflect joint ownership. Once permission is granted the issue will be scheduled for printing, Charrow said, noting that the process can take up to three months.

“The matters before the Patent Office take time,” Charrow said, “but there’s no controversy. It took a while to collect all the necessary signatures. But now that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies